This protocol is judged by an institutional evaluation board, an unbiased group that critiques any clinical trials involving individuals. If a review involves a Plan I drug, once the board approves the protocol as ethical, the researchers need to apply for an investigational new drug (IND) quantity in the FDA. https://copyright-for-sale-renewable-e16890.daneblogger.com/36237323/5-easy-facts-about-ecstasy-for-sale-described